4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008744
Director bought 200,000 shares at $20.00 ($4,000,000)
- Director sold 164 shares at $20.00 ($3,280)
- Director acquired 46,608 shares (option exercise)
- Director acquired 1,997,991 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion | +1,092,080 | 1,117,184 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion | +317,922 | 1,435,106 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion | +345,568 | 1,780,674 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Option exercise | +40,953 | $0.07 | $2,867 | 1,821,627 | I |
| ENGLEMAN EDGAR Director | 2021-02-09 | Sale | −144 | $20.00 | $2,880 | 1,821,483 | I |
| ENGLEMAN EDGAR Director | 2021-02-09 | Purchase | +175,733 | $20.00 | $3,514,660 | 1,997,216 | I |
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion | +150,802 | 154,268 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion | +43,901 | 198,169 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion | +47,718 | 245,887 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Option exercise | +5,655 | $0.07 | $396 | 251,542 | I |
| ENGLEMAN EDGAR Director | 2021-02-09 | Sale | −20 | $20.00 | $400 | 251,522 | I |
| ENGLEMAN EDGAR Director | 2021-02-09 | Purchase | +24,267 | $20.00 | $485,340 | 275,789 | I |
| Derivatives | |||||||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion · Series B Preferred Stock | −1,092,080 | 0 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion · Series C- 1 Preferred Stock | −317,922 | 0 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion · Series C- 2 Preferred Stock | −345,568 | 0 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Option exercise · Warrant (Right to Buy) | −40,953 | 0 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion · Series B Preferred Stock | −150,802 | 0 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion · Series C- 1 Preferred Stock | −43,901 | 0 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Conversion · Series C- 2 Preferred Stock | −47,718 | 0 | I | ||
| ENGLEMAN EDGAR Director | 2021-02-09 | Option exercise · Warrant (Right to Buy) | −5,655 | 0 | I | ||
| Open-market purchases · 200,000 sh · avg $20.00 · $4,000,000 | |||||||
| Open-market sales · 164 sh · avg $20.00 · $3,280 | |||||||
Loading xslF345X03/doc4.xml…